For Penn
For Industry
PCI Ventures
Innovation at Penn
Info
Available Technologies
Browse Penn-owned technologies available for licensing.
HOME
SEARCH
RSS FEED
anti-GPVI (Mouse)
Case ID:
TRM-N2626
Web Published:
1/3/2012
Monoclonal (IgG)
Clone:
Hy101 (or 11A12)
Applications:
Flow cytometry, WB, binding inhibition in vitro
Species Reactivity:
Human
Alternative Names:
GP 6
Immunogen:
GPVI R272L expressed on 3T3 cells
Relevant Publications:
[Flow cytometry, WB] -
Chen H, Locke D, Liu Y, Liu C, Kahn ML. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion. J Biol Chem. 2002 Jan 25;277(4):3011-9
[Pubmed: 11723134]
[binding inhibition in vitro] -
Sarratt KL, Chen H, Zutter MM, Santoro SA, Hammer DA, Kahn ML. GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood. 2005 Aug 15;106(4):1268-77.
[Pubmed: 15886326]
[Flow cytometry] -
Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost. 2009 Aug;7(8):1356-63
[Pubmed: 19552682]
Tech-ID:
N2626
Patent Information:
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://upenn.technologypublisher.com/technology/8560
Category(s):
Research Tools & Reagents
Bookmark this page
Download as PDF
For Information, Contact:
Research Reagents
Technology Publisher Search Account
University of Pennsylvania
pciinfo@pci.upenn.edu
Inventors:
Keywords: